Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Illegal Marketing of Bextra and Other Drugs

In September 2009, Pfizer agreed to pay $2.3 billion to settle federal and state civil and criminal allegations that it had illegally marketed four drugs — Bextra, Geodon, Zyvox, and Lyrica — with the intent to defraud or mislead by promoting the drugs for non-approved uses. $1.3 billion of that was paid by Pfizer subsidiary Pharmacia & Upjohn Company, Inc., which pleaded guilty to a felony violation of the Food, Drug and Cosmetic Act for its promotion of Bextra. Pfizer paid a $1 billion civil fine to settle allegations it had illegally promoted the drugs for uses that were not approved by the U.S. Food and Drug Administration (FDA) and caused false claims to be submitted to Medicare and Medicaid programs. Pfizer denied all of the civil allegations, with the exception that Pfizer acknowledged certain improper actions related to the promotion of Zyvox.

Misconduct Type
Health
Enforcement Agency
Multiple Agencies
Contracting Party
None
Court Type
Criminal
Disposition
Pleaded Guilty
Date of Announcement
9/2/2009
Contractors Involved Penalty
Total
Pfizer, Inc. $2,300,000,000
Further Information Released
Corporate Integrity Agreement 3/24/2010
DOJ Press Release 3/24/2010
Pfizer Press Release 3/24/2010
Sentencing Memorandum 3/24/2010

See also:

Federal Contractor Misconduct Database